Publications

Filters: policy
x
Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

EGA-EBG Considerations on WHO’s BQ Proposal – Suzette Kox, WHO INN Open Session with Stakeholders, Geneva, 13 October 2015 (PPT)

13 October 2015

Policy

Open

Investing in People Centred Health Service Delivery – Paul Cornes, Riga Health Conference – How to Improve Health Systems Through Technology? 29-30 June 2015, Riga, Latvia (PPT)

29 June 2015

Policy

Open

Launch of European Value Added medicines (EVA), a new EGA sector group, will deliver efficiency

12 June 2015

Policy

Brussels – The European Generic and Biosimilar medicines Association (EGA) announced […]

Read more

EMA & Biosimilar Update: Trends from marketing authorisation applications, scientific advice procedures and policies – Peter Richardson, EBG Biosimilars 2015, London (PPT)

24 April 2015

Policy

Open

The Science of Extrapolation – Martina Weise, EBG Biosimilars 2015, London (PPT)

23 April 2015

Policy

To view the full presentation, please click here. Part I […]

Read more

Considerations on WHO’s BQ Proposal – Joerg Windisch, 60th INN Consultation WHO, Geneva, 13 April 2015 (PPT)

13 April 2015

Policy

Open

French Parliament Public Hearing on Biosimilar Medicines, Paris, 29 January 2015 – Intervention from EMA Spokesperson Camille Vleminckx

29 January 2015

Policy

Open

Labelling & Naming – EBG Perspective, DIA Berlin 2014

3 December 2014

Policy

Open

WHO BQ Proposal – EGA’s perspective, 59th INN Consultation, WHO, Geneva, 14 October 2014

14 October 2014

Policy

Open

EMA mAb Workshop – Guideline on Similar Biological Medicinal Products

31 October 2013

Policy, Video

View

Subscribe to our newsletter